SDF-1 is both necessary and sufficient to promote proliferative retinopathy

Journal of Clinical Investigation

Volumn 115, Issue 1, 2005, Pages 86-93

  Butler, Jason M ^a   Guthrie, Steven M ^a   Koc, Mehmet ^a   Afzal, Aqeela ^a   Caballero, Sergio ^a   Brooks, H Logan ^a   Mames, Robert N ^a   Segal, Mark S ^a   Grant, Maria B ^a   Scott, Edward W ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 310; OCCLUDIN; OXYGEN; STROMAL CELL DERIVED FACTOR 1; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 4; ALPHA CHEMOKINE; ANTIBODY; CORTICOSTEROID; TRIAMCINOLONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLINDNESS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DIABETIC RETINOPATHY; DRUG TARGETING; ENDOTHELIUM CELL; GLAUCOMA; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; SIDE EFFECT; TIGHT JUNCTION; VITREOUS BODY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; ENZYMOLOGY; IMMUNOLOGY; ISCHEMIA; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA NEOVASCULARIZATION; TITRIMETRY;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ANTIBODIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES, CXC; DIABETIC RETINOPATHY; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; MIDDLE AGED; RETINAL NEOVASCULARIZATION; TITRIMETRY; TRIAMCINOLONE;

EID: 85047690920     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22869     Document Type: Article

References (36)

1. Kaufmann, P., and Alm, A. 2003. Adler's physiology of the eye. 10th edition. Mosby. St. Louis, Missouri, USA. 876 pp.
2. Grant, M.B., et al. 2002. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8:607-612.
3. Sengupta, N., et al. 2003. The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44:4908-4913.
4. Cogle, C.R., et al. 2004. Adult human hematopoietic cells provide functional hemangioblast activity. Blood. 103:133-135.
5. Guthrie, S.M., Curtis, L.M., Mames, R.N., Simon, G.G., and Scott, E.W. 2004. The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood. doi:10.1182/blood-2004-09-3415.
6. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9-22.
7. Witmer, A.N., Vrensen, G.F., Van Noorden, C.J., and Schlingemann, R.O. 2003. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22:1-29.
8. Aiello, L.P., et al. 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U. S. A. 92:10457-10461.
9. Ceradini, D.J., et al. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858-864.
10. Hattori, K., Heissig, B., and Rafii, S. 2003. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk. Lymphoma. 44:575-582.
11. Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C., and Weissman, I.L. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195:1145-1154.
12. Hatch, H., Zhang, D., Jorgensen, M.S., and Petersen, B.E. 2002. SDF-1/CXCR-4: A possible mechanism for bone marrow derived hepatic oval cell recruitment to the rat liver. Cloning Stem Cells. 4:339-352.
13. Sjostrand, J., Karlsson, J.O., and Andersson, A.K. 1992. Changes in the soluble protein of the human vitreous in vitreoretinal disease. Acta Ophthalmol. 70:814-819.
14. Tano, Y., Chandler, D., and Machemer, R. 1980. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am. J. Ophthalmol. 90:810-816.
15. McCuen, B.W., 2nd, Bessler, M., Tano, Y., Chandler, D., and Machemer, R. 1981. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am. J. Ophthalmol 91:785-788.
16. Jonas, J.B., Kreissig, I., Sofker, A., and Degenring, R.F. 2003. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch. Ophthalmol. 121:57-61.
17. Martidis, A., et al. 2002. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 109:920-927.
18. Jonas, J.B., Kreissig, I., and Degenring, R. 2003. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br. J. Ophthalmol. 87:24-27.
19. Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C., and Weissman, I.L. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195:1145-1154.
20. Lazarini, F., Tham, T.N., Casanova, P., Arenzana-Seisdedos, F., and Dubois-Dalcq, M. 2003. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia. 42:139-148.
21. Salcedo, R., et al. 1999. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol. 154:1125-1135.
22. Kijowski, J., et al. 2001. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells. 19:453-466.
23. Neuhaus, T., et al. 2003. Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif. 36:75-86.
24. Mirshahi, F., et al. 2000. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb. Res. 99:587-594.
25. Salvucci, O., et al. 2002. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood. 99:2703-2711.
26. Yamaguchi, J., et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 107:1322-1328.
27. Rafii, S., Heissig, B., and Hattori, K. 2002. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 9:631-641.
28. Suratt, B.T., et al. 2004. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood. 104:565-571.
29. Zhang, Y., and Stone, J. 1997. Role of astrocytes in the control of developing retinal vessels. Invest. Ophthalmol. Vis. Sci. 38:1653-1666.
30. Otani, A., et al. 2002. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8:1004-1010.
31. The Diabetic Retinopathy Study Research Group. 1976. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am. J. Ophthalmol. 81:383-396.
32. Wilson, C.A., et al. 1992. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch. Ophthalmol. 110:1155-1159.
33. Jaffe, E.A., Hoyer, L.W., and Nachman, R.L. 1974. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 71:1906-1909.
34. Chen, Y., et al. 1999. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J. Mol. Biol. 293:865-881.
35. Ruckman, J., et al. 1998. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273:20556-20567.
36. Grant, M.G., and Guay, C. 1991. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin. Invest. Ophthalmol. Vis. Sci. 32:53-64.